ACTA1 and Hepatic fibrosis: Of note, Bsep-/- animals challenged with TAA showed also reduced hepatic inflammation (MAC-2) and hepatic fibrosis (PSR) as well as reduced numbers of αSMA-positive cells when compared with WT TAA animals (Figure 5).